The Role of Complex Therapy in Reducing Complications of Odontogenic Periostitis in Elderly Patients
Keywords:
Oral Surgery Elderly Patients, Complex Therapy, Inflammatory Complications, Oral Surgery, Dental Infections, Antimicrobial Therapy, Postoperative Rehabilitation, Maxillofacial Inflammation, Geriatric Dentistry, Odontogenic PeriostitisAbstract
Nowadays odontogenic periostitis remains one of the most common inflammatory diseases in maxillofacial surgery, especially among elderly patients with concomitant somatic disorders and reduced immune resistance. Age-related physiological changes often contribute to a more severe clinical course, delayed tissue regeneration, and increased risk of complications. Therefore, improving treatment effectiveness in this category of patients is an important issue in modern dentistry and oral surgery.
References
[1] L. J. Peterson, E. Ellis, J. R. Hupp, and M. R. Tucker, Contemporary Oral and Maxillofacial Surgery, 7th ed. St. Louis, MO, USA: Mosby Elsevier, 2019.
[2] R. G. Topazian, M. H. Goldberg, and J. R. Hupp, Oral and Maxillofacial Infections, 5th ed. Philadelphia, PA, USA: Saunders Elsevier, 2018.
[3] J. R. Vane and R. M. Botting, “Mechanism of action of nonsteroidal anti-inflammatory drugs,” American Journal of Medicine, vol. 104, no. 3A, pp. 2S–8S, 2017.
[4] P. J. Nathan, K. Lu, M. Gray, and C. Oliver, “The neuropharmacology of L-theanine and its possible therapeutic applications,” Journal of Herbal Pharmacotherapy, vol. 6, no. 2, pp. 21–30, 2016.
[5] K. Kimura, M. Ozeki, L. R. Juneja, and H. Ohira, “L-theanine reduces psychological and physiological stress responses,” Biological Psychology, vol. 74, no. 1, pp. 39–45, 2017.
[6] V. N. Balin and V. I. Babiyak, Inflammatory Diseases of the Maxillofacial Region and Neck. Moscow, Russia: Meditsina, 2020.
[7] P. R. Murray, K. S. Rosenthal, and M. A. Pfaller, Medical Microbiology, 9th ed. Philadelphia, PA, USA: Elsevier, 2021.
[8] L. G. Koss and M. R. Melamed, Koss’ Diagnostic Cytology and Its Histopathologic Bases, 6th ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins, 2020.
[9] C. G. Jones, “Chlorhexidine: Is it still the gold standard?” Periodontology 2000, vol. 15, no. 1, pp. 55–62, 2019.
[10] H. M. Fillit, K. Rockwood, and J. B. Young, Brocklehurst’s Textbook of Geriatric Medicine and Gerontology, 8th ed. Philadelphia, PA, USA: Elsevier, 2018.
[11] M. A. Pogrel and D. A. Stern, Complications in Oral and Maxillofacial Surgery. Chicago, IL, USA: Quintessence Publishing, 2019.
[12] J. W. Little, D. A. Falace, C. S. Miller, and N. L. Rhodus, Dental Management of the Medically Compromised Patient, 9th ed. St. Louis, MO, USA: Elsevier, 2018.
[13] S. Scully and J. V. Bagan, “Oral mucosal disease: Odontogenic infections and inflammatory disorders,” British Dental Journal, vol. 223, no. 9, pp. 635–640, 2017.
[14] A. H. Brook, “Microbiology and management of odontogenic infections in elderly patients,” Journal of Oral and Maxillofacial Surgery, vol. 76, no. 4, pp. 689–696, 2018.
[15] J. E. Hupp and E. Ellis, “Management of maxillofacial infections in geriatric patients,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 125, no. 3, pp. 215–223, 2018.
[16] S. Greenberg and M. Glick, Burket’s Oral Medicine, 13th ed. Shelton, CT, USA: PMPH USA, 2021.
